Patients with SLE produce autoantibodies against Ro60 which is an evolutionarily conserved RNA binding protein, and the antibody against Ro60 is the most common and earliest preclinical anti-nuclear antibody (80). This evidence concerns the gene RO60 and systemic lupus erythematosus.